Overview This page contains the latest trade data of Glands and Other Organs. In 2023, Glands and Other Organs were the world's 545th most traded product, with a total trade of $4.97B. Between 2022 and 2023 the exports of Glands and Other Organs decreased by -14.5%, from $5.81B to $4.97B. Trade in Glands and Other Organs represent 0.022% of total world trade.
Glands and Other Organs are a part of Pharmaceutical products. They include Heparin, salts, for therapeutic use, Extracts of glands etc. for therapeutic use, and Glands and other organs, dried, for therapeutic uses.
Exports In 2023 the top exporters of Glands and Other Organs were China ($850M), United States ($776M), Singapore ($631M), France ($614M), and Spain ($395M).
Imports In 2023 the top importers of Glands and Other Organs were France ($919M), Singapore ($537M), United States ($441M), Spain ($366M), and Hungary ($290M).
Ranking Glands and Other Organs ranks 368th in the Product Complexity Index (PCI).
Description Dried glands and other organs for organo-therapeutic uses are used for their supposed medicinal properties. Extracts of glands or other organs or their secretions, for organo-therapeutic uses, are used to treat many ailments. Heparin and its salts are used to prevent blood clots. Other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified, are used to treat many ailments.